Don't have an account? To participate in discussions consider signing up or signing in
facebook connect
Sign-up, its free! Close [x]

Benefits

  • okay Create lasting relationships with other like minded women.
  • okay Blogging, let your voice be heard!
  • okay Interact with other women through blogs,questions and groups.
  • okay Photo Album, upload your most recent vacation pictures.
  • okay Contests, Free weekly prize drawing.
  • okay Weekly Newsletter.

+1
Love it

Max International acquired the patents and intellectual propery of Cell Gevity in 2009.  New products have been announced and will be released in June 2010 based of the research of Dr. Nagasawa in Glutathione production.  

Max has positioned itself to be the leader in intra-cellular production of the body’s most important anti- oxidant- Glutathione.  The products that will be released later this year and for years to come will set the stage for improvements in health and wellness never seen before.

This is an incredibly exciting time for me.  There is nothing more rewarding than being able to improve other people’s quality of life.

Here is a brief bio on Dr. Nagasawa.

Herbert T. Nagasawa, Ph.D.: Co-Founder, Chairman and Director of Research
Chief Scientist and co-founder of CellGevity, Inc., Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and the Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA’s top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals, and is the inventor named on ten U.S. and PCT patent applications.  

Dana Cappelletti
[Link Removed]


Dana11, Your links have been removed, please consider upgrading to premium membership.

+1
Love it



Member Comments

About this author View Blog » 
author